Fixed drug eruptions in children - 08/09/11
Doi : 10.1016/S0022-3476(99)70472-5
Joseph G. Morelli, MD, Yong-Kwang Tay, MBBS, MRCP, Maureen Rogers, MBBS, FACD, Anne Halbert, MBBS, FACD, Bernice Krafchik, MB, ChB, FRCPC, William L. Weston, MD
Department of Dermatology, University of Colorado School of Medicine, Denver, Colorado; National Skin Center, Singapore; New Children’s Hospital, Eastwood, New South Wales; Royal Margaret Children’s Hospital, Perth, West Australia; and the Hospital for Sick Children, Toronto, Ontario, Canada
Abstract |
To determine the anatomic location and offending drug in fixed drug eruptions (FDE) in children, we performed a 5-year retrospective analysis. Thirty-five children with FDE were evaluated. The most common cause of FDE was the combination drug trimethoprim-sulfamethoxazole. (J Pediatr 1999;134:365-7)
Le texte complet de cet article est disponible en PDF.Abbreviations : FDE
Plan
 | Reprint requests: Joseph G. Morelli, MD, Department of Dermatology B-153, 4200 East Ninth Ave, Denver, CO 80262. |
| 0022-3476/99/$8.00 + 0 9/22/96320 |
© 1999
Mosby, Inc. Tous droits réservés.
Vol 134 - N° 3
P. 365-367 - mars 1999 Retour au numéro
Article précédent
- Celiac disease–associated alopecia in childhood
- Yehezkel Naveh, Eldad Rosenthal, Yehudith Ben-Arieh, Amos Etzioni
- Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate
- Janet A. Stockheim, Jorge J. Daaboul, Ram Yogev, Susan P. Scully, Helen J. Binns, Ellen Gould Chadwick
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?